Senseonics continues to make inroads in its rollout of the Eversense CGM.
An overview of insulin pump therapy, with Diabetes Care and Education Specialist Ashlee Ernst.
Medtronic now will launch a pivotal trial of the experimental infusion sets, not pictured here, with the aim of bringing them to market.
How the founder of Integrated Medical Sensors was motivated to develop better blood sugar monitoring options by his mother’s diabetes diagnosis.
Dexcom officials shared this news and more details about its pipeline of diabetes technology in a recent earnings call.
Presenters, including members of the T1D Exchange Quality Improvement Collaborative, discussed ways to raise awareness of the upside of CGM use among the patient population.
We talk with CEO Ed Damiano about the final stages of development to bring this device to market.
The medical device maker is hoping to keep costs down and increase access to its novel glucose monitoring device.
The move was made just a week after the FDA met with hackers who created an app to expose the vulnerability of the older insulin pumps, according to a Wired report.
Sanofi’s $4 million investment comes shortly after news that Biocorp has gained European approval for its smart cap as a new class of medical device.